1)  oral premedication
口服用药
2)  oral
口服
1.
Oral Contraceptive-induced Portal Vein Cavernous Transformation with Multiple Thrombosis:A Case Report;
口服避孕药致门静脉海绵样变性伴多发性血栓1例
2.
Transferrin in peroral delivery of protein and peptide;
转铁蛋白在蛋白多肽药物口服给药中的应用
3.
Diagnostic value of oral SonoVue in contrast-enhanced ultrasound examination of stomach:a preliminary study;
口服SonoVue胃腔超声造影诊断价值的初步评价
3)  Oral administration
口服
1.
Study on distribution of hyaluronic acid after oral administration in the rodent;
口服透明质酸在动物体内的分布
2.
Study on absorption of hyaluronic acid after an oral administration in rats;
口服透明质酸在大鼠体内吸收机制的研究
3.
Preliminary study on insulin oil solution for oral administration;
口服胰岛素油溶剂的初步研究
4)  oral absorption
口服吸收
1.
Intestinal peptide transporter and application for improving oral absorption;
小肠寡肽转运蛋白及其在提高药物口服吸收中的应用
2.
Prodrug is an effective way to improve the oral absorption of the drugs which belong to Biopharmaceuticals Classification System(BCS) class III and IV.
前药研究是提高生物药剂学分类系统中第III和IV类药物口服吸收的有效途径之一。
5)  Oral Solution
口服溶液
1.
Determination of Related Substances in Azithromycin Oral Solution by HPLC;
高效液相色谱法测定阿奇霉素口服溶液的有关物质
2.
Relative bioavailability of ambroxol hydrochloride oral solution in healthy volunteers;
盐酸氨溴索口服溶液的相对生物利用度研究
3.
Objective To establish a HPLC method for the determination of 4-aminophenol in paracetamol and dertromethorphan hydro-bromide oral solution.
目的 测定氨酚沙芬口服溶液中对氨基酚的量。
6)  oral liquid
口服液
1.
Preparation technology for antitussive oral liquid;
止咳口服液制备工艺研究
2.
Preparation of the nutrient oral liquid with the paphia undulate meat and the pineapple liquid;
波纹巴非蛤肉及菠萝汁营养口服液的研制
3.
Determination of the content of zinc in oral liquid by micro-emulsion spectrophotometry;
用微乳液分光光度法测定口服液中锌的含量
参考词条
补充资料：5FU联合用药方案


5FU联合用药方案


　　主要用于滋养细胞肿瘤晚期(ⅢB和Ⅳ期)病人，通常两药合用。5FU加KSM(更生霉素)或5FU加AT1258(消瘤芥)。联合用药时5FU用量减至每天每千克体重26mg左右，KSM用量为每天每千克体重6μg(一般每天用300μg)，分别溶于1000ml 5%葡萄糖溶液中，先滴5FU，完后用KSM。5FU加AT1258方案：AT1258 1次用量20～30mg，5FU每千克体重26mg，先静脉注射AT1258再滴5FU，两药合用8天为一疗程。间隔为3周。对耐药病人，如耐药原因是5FU用药量偏小，则常用5FU加KSM加AT1258三药联合应用，其剂量与二药联合方案相同。必要时三药方案与长春新碱合用，先用长春新碱1～2mg，再依次用AT1258，5FU和KSM，三药剂量不减，但疗程缩短至5～6天。疗程间隔为4周，依不良反应消退时间而定。
　　
说明：补充资料仅用于学习参考，请勿用于其它任何用途。